Artivion [AORT] vs QuidelOrtho [QDEL] Detailed Stock Comparison
Artivion
NYSE
Loading...
QuidelOrtho
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Artivion wins in 9 metrics, QuidelOrtho wins in 8 metrics, with 0 ties. Artivion appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Artivion | QuidelOrtho | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | -0.78 | N/A |
| Price-to-Book Ratio | 4.59 | 0.58 | QuidelOrtho |
| Debt-to-Equity Ratio | 62.81 | 100.33 | Artivion |
| PEG Ratio | 170.63 | 9.02 | QuidelOrtho |
| EV/EBITDA | 47.06 | 7.37 | QuidelOrtho |
| Profit Margin (TTM) | -4.43% | -17.01% | Artivion |
| Operating Margin (TTM) | 9.72% | -0.73% | Artivion |
| EBITDA Margin (TTM) | 9.72% | N/A | N/A |
| Return on Equity | -5.02% | -15.64% | Artivion |
| Return on Assets (TTM) | 1.70% | 1.36% | Artivion |
| Free Cash Flow (TTM) | $11.05M | $-112.10M | Artivion |
| 1-Year Return | 64.79% | -42.55% | Artivion |
| Price-to-Sales Ratio (TTM) | 4.76 | 0.59 | QuidelOrtho |
| Enterprise Value | $2.14B | $4.27B | QuidelOrtho |
| EV/Revenue Ratio | 5.29 | 1.56 | QuidelOrtho |
| Gross Profit Margin (TTM) | 64.23% | 44.78% | Artivion |
| Revenue per Share (TTM) | $10 | $41 | QuidelOrtho |
| Earnings per Share (Diluted) | $-0.43 | $-6.84 | Artivion |
| Beta (Stock Volatility) | 1.64 | -0.03 | QuidelOrtho |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Artivion vs QuidelOrtho Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Artivion | 25.23% | 32.44% | 33.91% | 43.53% | 34.17% | 45.83% |
| QuidelOrtho | -2.01% | 4.82% | -22.42% | -34.42% | -44.25% | -46.91% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Artivion | 64.79% | 80.24% | 97.83% | 287.78% | 672.64% | 515.79% |
| QuidelOrtho | -42.55% | -71.57% | -90.28% | 13.75% | 97.11% | 233.94% |
Performance & Financial Health Analysis: Artivion vs QuidelOrtho
| Metric | AORT | QDEL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.93B | $1.62B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 496,970 | 1,779,980 |
| 90 Day Avg. Volume | 383,297 | 1,818,280 |
| Last Close | $40.95 | $23.91 |
| 52 Week Range | $21.97 - $40.96 | $22.05 - $49.45 |
| % from 52W High | -0.02% | -51.65% |
| All-Time High | $44.82 (Jul 30, 2001) | $306.72 (Aug 03, 2020) |
| % from All-Time High | -8.63% | -92.20% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | -0.04% |
| Quarterly Earnings Growth | 0.02% | -0.04% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | -0.17% |
| Operating Margin (TTM) | 0.10% | -0.01% |
| Return on Equity (TTM) | -0.05% | -0.16% |
| Debt to Equity (MRQ) | 62.81 | 100.33 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.91 | $41.25 |
| Cash per Share (MRQ) | $1.13 | $2.25 |
| Operating Cash Flow (TTM) | $19.65M | $200.40M |
| Levered Free Cash Flow (TTM) | $-12,697,875 | $410.48M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Artivion vs QuidelOrtho
| Metric | AORT | QDEL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | -0.78 |
| Forward P/E | 170.63 | 9.02 |
| PEG Ratio | 170.63 | 9.02 |
| Price to Sales (TTM) | 4.76 | 0.59 |
| Price to Book (MRQ) | 4.59 | 0.58 |
| Market Capitalization | ||
| Market Capitalization | $1.93B | $1.62B |
| Enterprise Value | $2.14B | $4.27B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.29 | 1.56 |
| Enterprise to EBITDA | 47.06 | 7.37 |
| Risk & Other Metrics | ||
| Beta | 1.64 | -0.03 |
| Book Value per Share (MRQ) | $8.91 | $41.25 |
Financial Statements Comparison: Artivion vs QuidelOrtho
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AORT | QDEL |
|---|---|---|
| Revenue/Sales | $98.98M | $692.80M |
| Cost of Goods Sold | $35.40M | $349.50M |
| Gross Profit | $63.58M | $343.30M |
| Research & Development | $6.73M | $53.20M |
| Operating Income (EBIT) | $2.15M | $48.70M |
| EBITDA | $10.81M | $154.20M |
| Pre-Tax Income | $-2.30M | $-8.80M |
| Income Tax | $-1.79M | $3.90M |
| Net Income (Profit) | $-505,000 | $-12.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AORT | QDEL |
|---|---|---|
| Cash & Equivalents | $37.69M | $127.10M |
| Total Current Assets | $287.30M | $1.26B |
| Total Current Liabilities | $51.94M | $1.05B |
| Long-Term Debt | $356.98M | $2.27B |
| Total Shareholders Equity | $294.25M | $3.00B |
| Retained Earnings | $-61.77M | $123.10M |
| Property, Plant & Equipment | $77.04M | $2.35B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AORT | QDEL |
|---|---|---|
| Operating Cash Flow | $-17.94M | $41.90M |
| Capital Expenditures | N/A | $-56.20M |
| Free Cash Flow | $-20.59M | $9.40M |
| Debt Repayment | $-66,000 | $-36.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AORT | QDEL |
|---|---|---|
| Shares Short | 1.36M | 6.25M |
| Short Ratio | 3.74 | 3.68 |
| Short % of Float | 0.04% | 0.15% |
| Average Daily Volume (10 Day) | 496,970 | 1,779,980 |
| Average Daily Volume (90 Day) | 383,297 | 1,818,280 |
| Shares Outstanding | 41.95M | 67.26M |
| Float Shares | 41.69M | 62.60M |
| % Held by Insiders | 0.05% | 0.01% |
| % Held by Institutions | 0.89% | 1.15% |
Dividend Analysis & Yield Comparison: Artivion vs QuidelOrtho
| Metric | AORT | QDEL |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |